RecruitingNot ApplicableNCT05899361

A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest

A Pilot Study of a Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest for Surgical Dissection Within Urologic Regions of Interest.

Sponsor

Dana-Farber Cancer Institute

Enrollment

10 participants

Start Date

Aug 30, 2023

Study Type

INTERVENTIONAL

Conditions

Prostate Cancer Urologic Cancer Bladder Cancer Kidney Cancer Testicular Cancer Penile Cancer Urethral Cancer Urologic Neoplasms

Summary

This research study is a pilot clinical trial, which hypothesizes that the combination of electromagnetic tracking in conjunction with laparoscope imaging and ultrasound probe imaging will aid in reducing the complexity of both laparoscopic lymphadenectomy and/or organ removal in patients with a confirmed diagnosis of cancer in urologic regions of interest (Bladder, Prostate, Testicular, Kidney, Urethral, and Penis), by resulting in better visualization and more accurate localization of certain areas in the diseased organ or the diseased lymph node, and allowing for improved surgical and patient outcomes, fewer complications and better clinician performance.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a new imaging method to better identify lymph nodes and organs during urologic cancer surgery, which could help surgeons more accurately determine whether cancer has spread. **You may be eligible if...** - You are 18 or older with a confirmed or suspected diagnosis of a urologic cancer (bladder, prostate, testicle, kidney, ureter, urethra, penis, or scrotum) - You have had a CT, PET, or MRI scan at Brigham and Women's Hospital in the past year - You are scheduled to undergo lymph node removal or urologic organ removal surgery at that hospital **You may NOT be eligible if...** - Your kidney function is severely impaired (eGFR below 30) - You have serious uncontrolled medical conditions - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.